Recent research emerging from the University of Georgia has unveiled compelling evidence linking both e-cigarette and traditional cigarette use to an elevated risk of developing diabetes and prediabetes. This groundbreaking study challenges the prevailing notion that electronic cigarettes, often marketed as a safer alternative to conventional smoking, are devoid of significant metabolic health consequences. Instead, it reveals a nuanced and alarming connection between vaping, smoking, and the escalating prevalence of metabolic disorders in the U.S. population.
Utilizing an extensive dataset exceeding 1.2 million data points collected from the Behavioral Risk Factor Surveillance System, researchers have embarked on a comprehensive analysis to unravel the multifaceted relationship between tobacco product use and metabolic health outcomes. The findings are unequivocal: individuals who use e-cigarettes, cigarettes, or both are significantly more likely to be diagnosed with prediabetes or diabetes compared to nonsmokers. This association persists across diverse demographic groups and is exacerbated by pre-existing health conditions and socioeconomic factors.
The study specifically quantifies the risk, demonstrating that e-cigarette users exhibit a 7% increased likelihood of developing prediabetes, a critical precursor to type 2 diabetes. While this incremental risk may appear modest at first glance, it translates into approximately 7,000 additional prediabetes cases annually across the United States. Traditional cigarette and cigar smokers face an even greater risk elevation of 15%, while dual users of both cigarettes and e-cigarettes suffer a staggering 28% heightened risk, underscoring a potentially synergistic detriment from combined usage.
These associations are further complicated by the physiological mechanisms underpinning e-cigarette use. Emerging evidence suggests that vaping may induce short-term insulin resistance and promote weight gain, both of which are established precursors to the metabolic dysregulation observed in prediabetes. Such metabolic perturbations highlight that the consequences of e-cigarette use extend beyond pulmonary effects, implicating systemic processes that govern glucose metabolism and insulin sensitivity.
The significance of these findings becomes even more apparent when considering the demographic disparities illuminated by the research. Hispanic, Black, and Asian populations exhibit disproportionately higher risks of prediabetes and diabetes diagnoses when engaged in smoking or vaping behaviors compared to their white counterparts. This disparity likely reflects complex interactions between genetic susceptibility, environmental exposures, and socioeconomic stressors that collectively exacerbate vulnerability to metabolic diseases.
Socioeconomic status emerges as another potent modifier of risk, with individuals in lower income brackets experiencing a 12% greater likelihood of developing diabetes-related conditions in the context of smoking or vaping. Chronic stress associated with financial hardship is posited to contribute to maladaptive coping behaviors such as tobacco and alcohol use, thereby compounding adverse health outcomes. This intersection of socioeconomic disadvantage and health risk behaviors underscores the pressing need for targeted public health interventions.
Moreover, the deleterious effects of tobacco product use are more pronounced among individuals with elevated body mass indices. Overweight and obese e-cigarette users display worsened metabolic outcomes relative to their normal-weight counterparts, suggesting that adiposity may amplify the risk conferred by vaping. This interplay highlights the intricate metabolic derangements fueled by both lifestyle factors and tobacco exposure.
Encouragingly, the study also identifies lifestyle modifications that may mitigate these risks. Regular physical exercise, for instance, appears to confer protective effects, reducing the risk of prediabetes among smokers by approximately 8%. This finding emphasizes that while tobacco use markedly elevates metabolic risk, behavioral interventions centered on improved physical activity can partially offset these dangers and improve health trajectories.
The implications of this research extend beyond individual health, bearing substantial public health ramifications given the rising prevalence of e-cigarette use, particularly among younger populations. As vaping gains popularity, there is a critical concern that rates of diabetes and prediabetes may escalate correspondingly, posing a formidable challenge to healthcare systems and preventive strategies nationwide.
Sulakshan Neupane, the study’s lead author and doctoral candidate at UGA’s College of Agricultural and Environmental Sciences, articulates the broader context of these findings: “In an era when e-cigarettes are marketed as a ‘safer’ alternative to smoking, this suggests they may carry a hidden peril and may be quietly contributing to long-term health problems like prediabetes and diabetes.” This perspective calls for a paradigm shift in how the public health community addresses vaping, implicating metabolic health alongside respiratory risks.
This research was collaboratively conducted by experts including Agricultural and Applied Economics Professor Wojciech J. Florkowski and Chandra Dhakal, a UGA Ph.D. graduate currently affiliated with the CDC Foundation. Their combined expertise facilitated a rigorous investigation published in the journal AJPM Focus, delineating the heterogeneous associations between e-cigarette use and diabetes prevalence among U.S. adults.
As public awareness of these metabolic risks grows, the study advocates for enhanced surveillance and regulatory measures targeting tobacco product consumption. Incorporating metabolic health outcomes into the risk profiles of vaping and smoking could fundamentally alter prevention campaigns and clinical approaches, ultimately aiming to curb the dual epidemics of tobacco use and metabolic disease.
In sum, this pivotal research adds a critical dimension to the discourse on e-cigarettes, exposing their potential role in fueling the diabetes epidemic. It underscores an urgent call to action to reevaluate the health implications of vaping, encouraging integrated policies and interventions that address the full spectrum of tobacco-associated health risks beyond the respiratory system.
Subject of Research: The association between e-cigarette and cigarette use and the prevalence of diabetes and prediabetes among U.S. adults.
Article Title: Heterogeneous Association Between E-Cigarette Use and Diabetes Prevalence Among U.S. Adults
News Publication Date: 30-Jun-2025
Web References:
https://www.sciencedirect.com/science/article/pii/S2773065424000993?via%3Dihub
http://dx.doi.org/10.1016/j.focus.2024.100281
References:
Neupane, S., Florkowski, W. J., & Dhakal, C. (2025). Heterogeneous Association Between E-Cigarette Use and Diabetes Prevalence Among U.S. Adults. AJPM Focus. DOI: 10.1016/j.focus.2024.100281
Image Credits: Not specified
Keywords
Combustion products, Human health, Health care
Tags: e-cigarette health consequenceselectronic cigarettes and health risksnicotine effects on diabetesprediabetes and tobacco userisk factors for diabetessmoking and diabetes risksmoking prevalence and diabetessocioeconomic factors and diabetestobacco products and metabolic disorderstraditional smoking health impactsUniversity of Georgia research findingsvaping and metabolic health
